INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2).

Saved in:
Bibliographic Details
Title: INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2).
Authors: Bersanelli M; Medicine and Surgery Department, University of Parma, Parma, Italy bersamel@libero.it.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Giannarelli D; Biostatistical Unit, Regina Elena National Cancer Institute, IRCCS, Rome, Italy., De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Pignata S; UC Oncologia Medica Uro-Ginecologica, Istituto Nazionale Tumori 'Fondazione G. Pascale', IRCCS, Napoli, Italy., Di Maio M; Department of Oncology, University of Turin, Torino, Italy.; Medical Oncology, Azienda Ospedaliera Ordine Mauriziano di Torino, Torino, Italy., Clemente A; Biostatistics and Clinical Research Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Verzoni E; SS.Oncologia Genitourinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Giusti R; Medical Oncology Unit, Sant'Andrea Hospital, Roma, Italy., Di Napoli M; UC Oncologia Medica Uro-Ginecologica, Istituto Nazionale Tumori 'Fondazione G. Pascale', IRCCS, Napoli, Italy., Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy., Ermacora P; Dipartimento di Oncologia, Presidio Ospedaliero Universitario Santa Maria della Misericordia, Azienda sanitaria universitaria integrata Friuli Centrale, Udine, Italy., Catino A; Medical Thoracic Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Scotti V; Radiation Oncology Unit, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy., Mazzoni F; Medical Oncology Unit, University Hospital Careggi, Firenze, Italy., Guglielmini PF; SC Oncologia, AO SS Antonio e Biagio e C. Arrigo, Alessandria, Italy., Veccia A; Medical Oncology, Santa Chiara Hospital, Trento, Italy., Maruzzo M; Oncologia Medica 1, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy., Rossi E; Medical Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Grossi F; Medical Oncology Department, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Casadei C; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Ficorella C; Department of Biotechnological and Applied Clinical Sciences, St Salvatore Hospital, University of L'Aquila, L'Aquila, Italy., Montesarchio V; UOC Oncologia, Azienda Ospedaliera Specialistica dei Colli, Ospedale Monaldi, Napoli, Italy., Verderame F; Oncology Department, Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy., Rizzo M; Oncologia Traslazionale, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy., Guaitoli G; Medical Oncology Unit, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy., Fratino L; Medical Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy., Accettura C; Medical Oncology Unit, Ospedale Vito Fazzi, Lecce, Italy., Mencoboni M; Oncologia Medica, Ospedale Villa Scassi, Genova, Italy., Zustovich F; UOC Oncologia di Belluno, Dipartimento di Oncologia Clinica, AULSS 1 Dolomiti, Ospedale S.Martino, Belluno, Italy., Baldessari C; Medical Oncology Unit, Universita degli Studi di Modena e Reggio Emilia, Modena, Italy., Cinieri S; Medical Oncology Division and Breast Unit, Senatore Antonio Perrino Hospital, Brindisi, Italy., Camerini A; Oncologia Medica, Ospedale della Versilia, Lido di Camaiore, Italy., Laera L; Medical Oncology, Ospedale Generale Regionale F Miulli, Acquaviva delle Fonti, Puglia, Italy., Sorarù M; Medical Oncology, Camposampiero Hospital, ULSS 6 Euganea, Padova, Italy., Zucali PA; Department of Oncology, Humanitas Clinical and Research Center, IRCCS, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Guadalupi V; UC Oncologia Medica Uro-Ginecologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Leonardi F; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Tiseo M; Medicine and Surgery Department, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Tognetto M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Di Costanzo F; Federation of Italian Cooperative Oncology Groups (FICOG), Milano, Italy., Pinto C; Medical Oncology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.; Presidency of the Federation of Italian Cooperative Oncology Groups (FICOG), Milan, Italy., Negrini G; Oncology, ASST Papa Giovanni XXIII, Bergamo, Italy., Russo A; Dipartimento di Discipline Chirurgiche, Oncologiche e Stomatologiche, Università degli Studi di Palermo, Palermo, Italy., Migliorino MR; Medical Oncology, San Camillo Forlanini Hospital, Roma, Italy., Filetti M; Department of Clinical and Molecular Medicine, Oncology Unit, Sant'Andrea Hospital, Sapienza University of Rome, Roma, Italy., Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
Corporate Authors: FICOG group (Federation of Italian Cooperative Oncology Groups)
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 May; Vol. 9 (5).
Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2021-002619